IMD-0560

OC1=CC=C(Br)C=C1C(=O)NC2=CC(=CC=C2C(F)(F)F)C(F)(F)F

InChIKey=SVGRIJCSKWXOPA-UHFFFAOYSA-N

InChI=1S/C15H8BrF6NO2/c16-8-2-4-12(24)9(6-8)13(25)23-11-5-7(14(17,18)19)1-3-10(11)15(20,21)22/h1-6,24H,(H,23,25)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

PubMed

Title	Date	PubMed
Effect of nuclear factor-kappaB inhibition on rheumatoid fibroblast-like synoviocytes and collagen induced arthritis.	2005 Aug	16078317
A novel IKK inhibitor suppresses heart failure and chronic remodeling after myocardial ischemia via MMP alteration.	2008 Dec	19007316

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 07:58:33 GMT 2023` Edited by `admin` on `Sat Dec 16 07:58:33 GMT 2023`
Record UNII	419X829330
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

IMD-0560

Common Name

English

BENZAMIDE, N-(2,5-BIS(TRIFLUOROMETHYL)PHENYL)-5-BROMO-2-HYDROXY-

Systematic Name

English

Code System Code Type Description

PUBCHEM

11464503

Created by admin on Sat Dec 16 07:58:33 GMT 2023 , Edited by admin on Sat Dec 16 07:58:33 GMT 2023

PRIMARY

CAS

439144-66-8

Created by admin on Sat Dec 16 07:58:33 GMT 2023 , Edited by admin on Sat Dec 16 07:58:33 GMT 2023

PRIMARY

FDA UNII

419X829330

Created by admin on Sat Dec 16 07:58:33 GMT 2023 , Edited by admin on Sat Dec 16 07:58:33 GMT 2023

PRIMARY

Related Record Type Details


					419X829330

IMD-0560

ACTIVE MOIETY